DK0656209T3 - Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser - Google Patents

Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser

Info

Publication number
DK0656209T3
DK0656209T3 DK94308467T DK94308467T DK0656209T3 DK 0656209 T3 DK0656209 T3 DK 0656209T3 DK 94308467 T DK94308467 T DK 94308467T DK 94308467 T DK94308467 T DK 94308467T DK 0656209 T3 DK0656209 T3 DK 0656209T3
Authority
DK
Denmark
Prior art keywords
treatment
melatonin derivatives
desynchronization disorders
disorders
desynchronization
Prior art date
Application number
DK94308467T
Other languages
Danish (da)
English (en)
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0656209T3 publication Critical patent/DK0656209T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94308467T 1993-11-18 1994-11-16 Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser DK0656209T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,903 US6180657B1 (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating desynchronization disorders

Publications (1)

Publication Number Publication Date
DK0656209T3 true DK0656209T3 (da) 2003-09-01

Family

ID=22553300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94308467T DK0656209T3 (da) 1993-11-18 1994-11-16 Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser

Country Status (21)

Country Link
US (1) US6180657B1 (cs)
EP (1) EP0656209B1 (cs)
JP (1) JPH07196504A (cs)
KR (1) KR950013509A (cs)
CN (1) CN1100533C (cs)
AT (1) ATE239470T1 (cs)
AU (1) AU7777694A (cs)
CA (1) CA2135710C (cs)
CZ (1) CZ288834B6 (cs)
DE (1) DE69432626T2 (cs)
DK (1) DK0656209T3 (cs)
ES (1) ES2197904T3 (cs)
HU (1) HUT72070A (cs)
IL (1) IL111579A (cs)
NO (1) NO307364B1 (cs)
NZ (1) NZ264893A (cs)
PT (1) PT656209E (cs)
RU (1) RU2160101C2 (cs)
SG (1) SG77569A1 (cs)
UA (1) UA35588C2 (cs)
ZA (1) ZA948928B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (en) * 1995-06-14 1997-05-21 Lilly Co Eli Melatonin agonists for the treatment of benign forms of hyperplasia of the prostate
WO2005062992A2 (en) * 2003-12-23 2005-07-14 Abraxis Bioscience, Inc Substituted melatonin derivatives, process for their preparation, and methods of use
AR061478A1 (es) * 2006-06-19 2008-08-27 Takeda Pharmaceutical Compuesto triciclico y composicion farmaceutica
WO2009140754A1 (en) * 2008-05-19 2009-11-26 F. Hoffmann-La Roche Ag An anti-cancer cytotoxic monoclonal antibody
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
IN2014DN07050A (cs) 2012-01-26 2015-04-10 Vanda Pharmaceuticals Inc
CN105142630A (zh) 2012-12-18 2015-12-09 万达制药公司 昼夜节律紊乱的治疗
RU2533965C1 (ru) * 2013-07-04 2014-11-27 Государственное бюджетное учреждение здравоохранения "Самарский областной гериатрический центр" Способ нормализации циркадианных ритмов человека
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
RU2655813C1 (ru) * 2017-06-09 2018-05-29 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Средство коррекции и профилактики состояний, вызванных нарушением суточных ритмов

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
DE3466215D1 (en) 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4600723A (en) 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
US4614807A (en) 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
IL79264A0 (en) 1986-06-27 1986-09-30 Univ Ramot Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
US4997845A (en) 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
US5093352A (en) 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
FI900801A7 (fi) 1987-08-17 1990-02-16 Nelson Res & Development Co Melantoniinianalogit
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
US5242941A (en) 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (it) 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
WO1993007870A1 (en) * 1991-10-18 1993-04-29 Alza Corporation Device for the transdermal administration of melatonin
US5196435A (en) 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
ZA948928B (en) 1996-05-10
IL111579A0 (en) 1995-01-24
DE69432626T2 (de) 2004-04-08
NZ264893A (en) 1997-06-24
CA2135710C (en) 2007-07-10
UA35588C2 (uk) 2001-04-16
CN1100533C (zh) 2003-02-05
CA2135710A1 (en) 1995-05-19
NO307364B1 (no) 2000-03-27
HU9403299D0 (en) 1995-01-30
RU2160101C2 (ru) 2000-12-10
JPH07196504A (ja) 1995-08-01
EP0656209B1 (en) 2003-05-07
KR950013509A (ko) 1995-06-15
SG77569A1 (en) 2001-01-16
HUT72070A (en) 1996-03-28
IL111579A (en) 1999-10-28
CN1107700A (zh) 1995-09-06
NO944340L (no) 1995-05-19
CZ276494A3 (en) 1995-07-12
NO944340D0 (no) 1994-11-14
US6180657B1 (en) 2001-01-30
EP0656209A2 (en) 1995-06-07
PT656209E (pt) 2003-09-30
DE69432626D1 (de) 2003-06-12
CZ288834B6 (cs) 2001-09-12
EP0656209A3 (en) 1995-10-11
ATE239470T1 (de) 2003-05-15
RU94041028A (ru) 1996-09-20
AU7777694A (en) 1995-05-25
ES2197904T3 (es) 2004-01-16

Similar Documents

Publication Publication Date Title
EP0751709A4 (en) METHODS FOR USE OF BCL-2 IN THERAPEUTIC TREATMENT AND PREVENTION OF DISEASES
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
EP0467164A3 (en) Use of the compound flupirtine against muscle bracing
EP0651650A4 (en) METHOD FOR TREATING EYE DISEASES BY MEANS OF TGF - g (b).
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DK0656209T3 (da) Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
NO990450D0 (no) Behandling av sinnslidelser
DK0693912T3 (da) Apparat til medicinsk behandling
DK1304107T3 (da) Anvendelse af oxozolidinonderivater til behandling af psoriasis
FI945035A0 (fi) Pintasterilisointi laserkäsittelyn avulla
ITRM920002A1 (it) Procedimento per il trattamento disinquinante, di residui contenenti caprolattame.
NO944055D0 (no) Overflatesterilisering ved laserbehandling